• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Palliative chemotherapy associated with more ICU treatment at end-of-life

byJordan AndersonandAndrew Bishara
March 7, 2014
in Chronic Disease, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Palliative chemotherapy for terminally ill patients was associated to more intensive care in the last week of life compared to those who did not undergo palliative chemotherapy.

2. There was no significant difference in survival outcomes between populations

Evidence Rating Level: 2 (Good)

Study Rundown: This study investigated how palliative chemotherapy impacts end-of-life care, looking specifically at use of intensive medical care during the last week of life. This study was conducted across nine different cancer centers with n=386 participants enrolled between 2002 and 2008. Within the population, 56% of the cancer patients began receiving palliative chemotherapy after enrolling in the study (n=216) and 44% did not (n=170). Among the patients who engaged in palliative chemotherapy, 14% (n=30) underwent intensive medical care in the last week of life; compared to 2% (n=3) in the group that did not undergo palliative chemotherapy (p<0.001). Additionally, researchers found no significant difference in survival outcomes between the two groups. This study provides little detail regarding clinical patient circumstances and given the small sample size of the study, the authors were tentative with their argument that palliative chemotherapy does not necessarily extend life.

Click to read the study in BMJ

Chemotherapy use among Medicare beneficiaries at the end of life

RELATED REPORTS

#VisualAbstract Ponatinib with FLAG-IDA is a feasible and active treatment strategy in patients with blast-phase chronic myeloid leukaemia

#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer

Neoadjuvant nivolumab improves survival in patients with resectable non-small cell lung cancer

In-Depth [prospective cohort study]: Researchers also analyzed the physical location of the patients’ death. Among those who received palliative chemotherapy during the study, 11% passed away in the intensive care unit; compared to 2% in the population that did not undergo palliative chemotherapy (p=0.02). As an additional note, researchers used a propensity score analysis to balance the various differences in patient populations. This was most apparent when looking at whether chemotherapy extended life by one week. Results showed that 89% of individuals who underwent palliative chemotherapy extended life by one week, compared to 62% among those who did not pursue palliative chemotherapy (p<.0.001). When the propensity analysis was applied, these percentages became 79.9% and 79.2% respectively, revealing no significant difference.

More from this author:  Medicaid beneficiaries among most frequent visitors to the emergency department; Emerging coronavirus found to spread in healthcare facilities; CT scans linked to cancer risk in children; Slowdown in healthcare costs linked to economic and clinical factors;

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: chemotherapycohort studyend-of-life carepalliative care
Previous Post

Rigorousness of Phase III trials for lung cancer may be declining

Next Post

Magnesium sulfate in torsade de pointes [Classics Series]

RelatedReports

#VisualAbstract Ponatinib with FLAG-IDA is a feasible and active treatment strategy in patients with blast-phase chronic myeloid leukaemia
StudyGraphics

#VisualAbstract Ponatinib with FLAG-IDA is a feasible and active treatment strategy in patients with blast-phase chronic myeloid leukaemia

June 12, 2022
#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer
StudyGraphics

#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer

May 18, 2022
Dacomitinib may be effective in EGFR-associated lung cancer
Chronic Disease

Neoadjuvant nivolumab improves survival in patients with resectable non-small cell lung cancer

May 9, 2022
#VisualAbstract: Neoadjuvant nivolumab plus chemotherapy increases event-free survival in resectable non-small-cell lung cancer
StudyGraphics

#VisualAbstract: Neoadjuvant nivolumab plus chemotherapy increases event-free survival in resectable non-small-cell lung cancer

April 28, 2022
Next Post
Classics Series, Landmark Trials in Medicine

Magnesium sulfate in torsade de pointes [Classics Series]

Social media effective adjunct for contraception education

Social media effective adjunct for contraception education

Preterm birth associated with elevated plasma insulin levels

Induction after 40 weeks in women with gestational diabetes associated with Cesarean delivery

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Intravenous fluid restriction does not improve septic shock outcomes
  • Intravenous vitamin C increases mortality and organ dysfunction in sepsis patients
  • Magnetic resonance based preoperative evaluation for perianal fistulas superior to traditional clinical method and improve surgical outcomes [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.